A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.

Meir Medical Center1,000 enrolled

Overview

Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Kidney Cancer Prostate Cancer Bladder Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age. Exclusion Criteria: * Patients under the age of 18

Locations (1)

Meir Medical Center

Kvar Saba, Israel

Outcomes

Primary Outcomes

Progression Free Survival

Univariate analysis will be used to assess the effects of clinical factors on progression free survival.

Time frame: 5 years

Secondary Outcomes

Patient overall survival

Univariate analysis will be used to assess the effects of clinical factors on overall survival.